Pharma Industry Review
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced on Saturday the first results from the
Read more
Adjuvant auxiliary drug carrier immunoadjuvant, Potent Immunological Adjuvants, sterile emulsion containing non-hazardous immune-active components balanced to give maximum effect. GERBU
Read more
GSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read more
Bristol Myers Squibb announced positive results from a Phase 3 Trial, which showed that neoadjuvant treatment with three cycles of
Read more
GSK has made an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support the production of
Read more
The GERBU Adjuvant P TM is developed specifically for polyclonal antibody production. Containing non-hazardous immuno active components, this adjuvant is
Read more
The GERBU Adjuvant MMTM is developed specifically for monoclonal antibody production and offers a high yield of IgG and fused
Read more
The GERBU FAMA AdjuvantTM is ideal for use in vaccine development. Powerful Immune-potentiating Adjuvant The GERBU AdjuvantTM is a powerful
Read more
Baxter International Inc., a world pioneer in the manufacture and supply of sterile medicines, revealed that Baxter BioPharma Solutions has
Read more
Novavax has announced the expansion of its Gaithersburg, Maryland campus to support global vaccine development through the addition of two
Read more